Expert Viewpoint: William J. Gradishar, MD
Professor, Division of Hematology and Medical OncologyNorthwestern UniversityThe Feinberg School of MedicineChicago, IL William J. Gradishar, MD, is Professor of Medicine in the Division of Hematology and Medical Oncology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. […]
HIV Infection Increases Heparin-Induced Thrombocytopenia Risk
By Will Boggs, MDPatients infected with HIV have an increased risk of developing heparin-induced thrombocytopenia (HIT), according to a report in the November 15th issue of Clinical Infectious Diseases.
Blood Transfusion Does Not Increase Prostate Cancer Recurrence Risk
Autologous blood transfusion (ABT) does not increase the risk of biochemical recurrence of prostate cancer after radical prostatectomy (RP), according to a report in the December issue of BJU International.
Risks of Transfusion
Bruce D. Spiess, MD, FAHAIntroductionBlood transfusion has evolved into a mainstay medical therapy. It has never undergone efficacy and safety testing the way in which a drug would be tested for approval by the US Food and Drug Administration.[1,2] Today, some 107 years after Karl Landsteiner discovered the ABO histocompatibility antigens, we are still learning […]
Models Predict Success With Growth Hormone Treatment
Mathematical models, particularly those incorporating both growth and endocrine data, can predict which short children will benefit from treatment with growth hormone (GH), according to a new study.
Patients With Alpha1-Antitrypsin Deficiency May Not Need Flu Vaccine
Despite guidelines that recommend influenza vaccination for patients with alpha1-antitrypsin deficiency (AATD), new research suggests that such vaccination has little impact on disease outcomes in those patients.
Noninvasive Positive Pressure Ventilation Improves Hypercapnia in Cystic Fibrosis
Nocturnal noninvasive positive pressure ventilation (NIV) reduces hypercapnia, improves symptoms, and increases exercise capacity in patients with cystic fibrosis (CF), according to a report in the January issue of Thorax.
ACP Addresses Potential Outcomes of Pay for Performance
News Author: Laurie Barclay, MDCME Author: Charles Vega, MD The American College of Physicians has issued recommendations to offset the potential adverse effects of pay-for-performance programs and to redirect the focus to the patient. Their position paper, which highlights the ethical implications of pay for performance and potential effects on the clinician-patient relationship, is published […]
Science and Sensibility: An Interview With Professor Rolf M. Zinkernagel
Science and Sensibility: An Interview With Professor Rolf M. Zinkernagel, Nobel Prize Winner for Medicine 1996 Interviewers: Hrishikesh Satish Kulkarni; Ajit H. Goenka, MBBSInterviewee: Rolf M. Zinkernagel, MD, PhDIntroduction Science is perceived to be the panacea to many of the world's problems. No wonder then that scores of brilliant minds are busy applying time-tested scientific […]
A treatment strategy for NSCLC
Expert OpinionNasser Hanna, MDIndiana UniversityNasser Hanna, MD, is an assistant professor at Indiana University, medical director for their Thoracic Oncology Program, and chair of the thoracic committee for the Hoosier Oncology Group. Recently, WebMD spoke with Dr Hanna about the current treatment options in previously treated NSCLC, treatment decisions in this setting, and the role […]
